Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

New paper using Attana Technology to study structures on surface in Ion Liquids demonstrating the effect of surface charges on interaction properties.

In the paper in "Journal of Colloid And Interface Science ", the Attana quartz crystal microbalance (QCM) is applied to study the electrical response of two ionic liquids. Controlled by an applied electric field, the structure and interaction of ionic liquids on the surface, can be monitored and optimized. This is of high importance for the development of e.g. environment friendly lubricants. This is the third paper by the team of Prof Rutland that demonstrates how Attana technology can be applied to monitor interaction

Save the date for the Alfa Laval Capital Markets Day on 21 November 2024

This year we will take the Capital Markets Day to southern Europe and visit our heat exchanger manufacturing site in San Bonifacio in Italy.The in-person event will include a site visit in one of Alfa Laval’s most advanced production facilities, as well as presentations from the CEO and other members of Group Management. The event will start in the morning of 21 November 2024 with a dinner the evening before. An invitation with further information and possibility to register to the event will be sent out closer to the event. For more information please contact:Johan LundinHead of

Observe Medical – First orders to the Irish Hospital Market

Oslo, February 13, 2024 - Observe Medical ("the Company" or "Observe Medical") has received first orders for delivery of UnoMeter™ 500 products from our distributor in Ireland, Armstrong Medical. We are set to dispatch 2,800 units of the UnoMeter™ 500 this week, with an additional 2,500 units scheduled for shipment by the end of February. The shipments are being facilitated via C&P Medical, our distributor based in the UK. This initial order places us well within the Urinemeter market in Ireland, which has an annual potential of approximately 15,000 units. Armstrong Medical will

Jouni Grönroos has decided to leave Fazer – Jukka Erlund appointed CFO for Fazer Group

Fazer Group’s CFO and Deputy CEO Jouni Grönroos has decided to leave Fazer. Jukka Erlund, M.Sc. (Econ), eMBA, (b. 1974) has been appointed as the company’s new Chief Financial Officer and member of the Fazer Leadership Team. He will assume his position in August at the latest.Jukka Erlund has worked at Kesko Corporation since 2004 and has been Executive Vice President, CFO in the company since 2011. Prior to this position, he served as Vice President for Finance in Kesko Food Ltd and has in addition also held several other major finance positions in the company during his career. Jukka

SRV’s change negotiations have been completed

SRV GROUP PLC                        STOCK EXCHANGE RELEASE                          13 FEBRUARY 2024 AT 15:00 EET  SRV’s change negotiations have been completed  SRV has today, Tuesday, completed change negotiations in accordance with the co-operation act. At the start of the negotiations, the company estimated that the need for permanent personnel reductions would be 35 person-years at most. The negotiations resulted in personnel reductions of a total of 19 person-years. In addition, 6 people will be laid off until further notice. As part of the negotiated solution, the company also

Change in Kesko’s Group Management Board

Kesko Corporation’s Chief Financial Officer Jukka Erlund has announced that he will be leaving Kesko and joining Fazer Group as Chief Financial Officer. Erlund has been Kesko’s CFO and a member of the Group Management Board since November 2011. Erlund will be leaving his current position by August 2024. Kesko has begun the process of finding a successor for Erlund. "Jukka Erlund has forged a long and successful career in Kesko since 2004. He has played a central role in Kesko’s growth, strategic transformation, and internationalisation. I want to express my warmest thanks to Jukka for

BiBB launches new website

The cancer diagnostics company BiBBInstruments AB ("BiBB" or the "Company"), the developer of the world's first market-cleared motorized endoscopic core biopsy instrument, announces that the Company has launched a new website with a new design and content that better reflects BiBB’s umcoming commercialization journey.Following the recent successes with market clearances in the USA and Europe for the EndoDrill[®] system, patent approvals in Europe, and successful clinical introduction in the USA, BiBB is launching a new website. The website features new graphics and updated text that better

NRC Group ASA - Appointed to contract in Norway - NOK 78 million

Å Energi Vannkraft has appointed NRC Norge AS, a company wholly owned by NRC Group ASA, to a contract for the renovation of Dam Nespervatn.  The contract is valued at approximately NOK 78 million, and the work will commence in May 2024 and is scheduled for completion in December 2025.  For further information, please contact: Ole Gulsvik, CFO of NRC Group, + 47 99 56 85 20. This information is considered to be inside information pursuant to the EU Market Abuse Regulation, and is subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading

Cereno Scientific announces new Executive Management Team

Cereno Scientific (Nasdaq First North: CRNO B) today announced that they have expanded the Executive Management Team to include the newly appointed Chief Medical Officer & Head of Research & Development, Rahul Agrawal, and the Business Development Director, Julia Fransson, to strengthen focus on the strategic priorities in development programs of lead candidate drug CS1 in PAH, and CS014 in thrombosis prevention and CS585 in not yet decided cardiovascular indication.The Executive Management Team now includes: · Chief Executive Officer (CEO) – Sten R. Sörensen · Chief Scientific

DOF Group ASA - CFO stepping down, Head of Investor Relations to take over

Hilde Drønen, CFO of DOF Group ASA, has decided to step down from her role by the end of 2024. Drønen has served the position as CFO since 2005. Martin Lundberg, SVP Finance and Head of Investor Relations, will be appointed as the new CFO for the Group and will work closely with Mrs. Drønen until the end of the year. CEO Mons S. Aase says: “I’ve been working together with Hilde for more than 25 years and I am thankful for her huge contribution and capacity through all these years. Hilde has provided the company with strong financial leadership and has been instrumental in

Cereno Scientific appoints Dr. Rahul Agrawal as Chief Medical Officer and Head of R&D

Cereno Scientific (Nasdaq First North: CRNO B) today announced that Dr. Rahul Agrawal has been appointed as Chief Medical Officer and Head of R&D. The recruitment follows an intense period in the clinical-stage biotech’s growth journey. Cereno is focused on developing innovative treatments for common and rare cardiovascular disease, with lead candidate drug CS1 currently in phase II for the orphan disease pulmonary arterial hypertension (PAH). On January 30th CS1 received FDA approval for Expanded Access also known as “Compassionate Use” after Cereno had received request to apply for CU from

Norconsult ASA: Invitation to presentation of Q4 and full year 2023 results

Norconsult ASA (NORCO) will release the fourth quarter and full year 2023 financial results on Tuesday 20 February 2024. The report and presentation will be made available at 7:00 CET at https://investor.norconsult.com and on NewsWeb. The Company will present the results at 09:00 CET at VIA – House of Oslo, Ruseløkkveien 34, Oslo. The presentation will be held by CEO Egil Hogna and CFO Dag Fladby. A live webcast will be available at https://videoforweb.aventia.no/embed/live/293?cameraId=2 In addition to questions from the audience, we will open up for questions sent to IR@norconsult.

Invitation to conference call and audiocast in connection with the year-end report

Stockholm, February 13, 2024 – Intervacc AB (publ) will publish the year-end report 2023 on Friday 16 February 2024 at 08:30 CET. CEO Jonas Sohlman and CFO Jan Persson will present the report at a conference call and audiocast held on 16 February 2024 at 11:00 CET. If you wish to participate, please use the link below. https://financialhearings.com/event/49867 For more information please contact:   Jonas Sohlman, CEO Phone: +46 (0)8 120 10 600, Cell: +46 (0) 70 576 30 73 E-mail: jonas.sohlman@intervacc.se   The information was submitted for publication, through the

Fortum's Financial Statements and Operating and Financial Review 2023 published

FORTUM CORPORATION STOCK EXCHANGE RELASE 13 FEBRUARY 2024 AT 13:30 EET Fortum's Financial Statements and Operating and Financial Review for 2023 and the Auditor's Report, have been published. The Financial Statements are published in accordance with the European Single Electronic Format (ESEF) reporting requirements. The Financials, the Governance Statement, the Remuneration Report, the Tax Footprint and the CEO’s Business Review for 2023 have also been published today. The material is attached to this release and available at www.fortum.com/annualreport2023. The Sustainability

Holding(s) in Company

TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB0032273343 Issuer Name BARINGS EMERGING EMEA OPPORTUNITIES PLC UK or Non-UK Issuer UK 2. Reason for Notification An acquisition or disposal of voting rights 3. Details of person subject to the notification obligation Name City of Bradford - West Yorkshire Pension Fund City of registered office (if applicable) BRADFORD Country of registered office (if applicable) United Kingdom 4. Details of the shareholder Full name of shareholder(s) if different from the

ABAX UK Elevates Asset Management with Advanced Tool Tracking Solutions at Executive Hire Show

Visit our stand K10 at the Coventry Arena - February 14th-15[th]ABAX UK, a pioneer in SMART MOBILITY solutions, is proud to announce its participation in the Executive Hire Show, taking place on February 14th and 15th. This event, a cornerstone for professionals in the hire industry, offers a unique opportunity to explore the forefront of technological advancements designed to streamline operations and enhance efficiency. ABAX's tracking solutions provide valuable insights into fleet, machinery, and tools, helping to lower the total cost of mobility, improve sustainability, and manage

Read original

Kemppi Oy and Kemppi Group Oy start change negotiations

KEMPPI        PRESS RELEASE        13 FEBRUARY 2024       13.15 EET Kemppi Oy and Kemppi Group Oy start change negotiations Kemppi Oy and Kemppi Group Oy have started change negotiations, the aim of which is to ensure maintaining group’s competitiveness and cost efficiency. "The planned measures are based on ensuring the competitiveness and cost efficiency of the welding business in the long term and strengthening the conditions for implementing our growth strategy," says Kemppi Oy's Interim CEO Katri Sahlman. The negotiations concern 445 employees in Finland. Companies

Six Invitational 2024 welcomes seven partners on board for the historic São Paulo event

BLAST and Ubisoft have brought on board seven partners ahead of this month’s historic Six Invitational 2024 set to take place in São Paulo, Brazil. The brands coming onboard for the Six Invitational 2024 are: · Intel - Official Event Partner · Lenovo - Official Laptop Partner · JBL - Official Peripheral Partner · Eureka Ergonomics - Official Gaming Chair Partner · Kingston Technology - Official SSD Partner · CTRL - Official Cookie Partner · Aura - Official Fibre Partner The prestigious Six Invitational 2024 is set to take place in São Paulo, Brazil from February

Green Feather Online to Accelerate Growth Strategy with Symplify Partnership

Symplify, the Stockholm-based market leader in CRM and AI cloud solutions, has put pen to paper on a new agreement with online casino operator Green Feather Online.The online casino operator manages a wide selection of successful consumer-facing sites that include Boo Casino, Mr Fortune Casino, B Casino and Galaxyno Casino. Symplify will be supporting Green Feather Online in creating another vital layer of engagement through its proprietary CRM, datahub, and multiple communication channels. There will be a special focus on email, SMS, dynamic web, web and browser push notifications.

Linxon energizes Saudi Arabia’s new Tanajib substation

Contracted by Samsung C&T Corporation and the Tanajib Cogeneration Power Company (TCPC), the 380 kV gas insulated substation (GIS) in the Eastern province is now operational.Energized in late December 2023, Linxon played a comprehensive role in delivering a new substation for end clients Aramco, Marubeni and Taqa. Specializing in end-to-end services encompassing design, manufacture, supply, delivery, installation and commissioning of Hitachi Energy power products, Linxon’s involvement included a full engineering, procurement, construction and commissioning solution. "We wish to thank

poLight ASA CTO Pierre Craen To Present Tunable Optics Update at PiezoMEMS 2024

HORTEN, Norway – February 13, 2024 -- poLight ASA  (OSE: PLT) announced that Chief Technology Officer Pierre Craen will present at the 10[th] PiezoMEMS 2024  workshop, highlighting the company’s proprietary polymer and piezo MEMS based TLens® product architecture and future tunable optics technology. The event, scheduled for March 19-20th in Aachen, Germany, brings together scientists and engineers representing a wide variety of applications. In addition to sharing details surrounding the commercial success of TLens®

AcuCort Update on Phase 4 Study: 10 Patients Recruited

AcuCort's Phase IV study ZEQ001 for Zeqmelit® is progressing as expected. The tenth patient has been allocated the oral film for use when needed for the treatment of acute allergic reactions.As previously communicated, the Phase IV study ZEQ001 regarding the oral film Zeqmelit® commenced at the end of January. The purpose of the study is to collect scientific data related to the launch in the Nordic region from practical experience of patients. The recruitment of patients for the study meets AcuCort's high expectations. Already after one week, ten allergy patients are included in the study,

There are no items matching the current filter
There are no more items matching the current filter
Back to top